Desq Long
Sign in
SEC FORM 4
$0.00

Phio Pharmaceuticals Corp. (PHIO)

Acquisition (code A) of 108,000 shares at $0 per share.

Reporting Person Carson Lisa Cabott · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 28, 2026 · Disclosed Sep 29, 2026

Source: SEC Form 4 · 0001683168-26-007481 · filed 2026-09-29 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Phio Pharmaceuticals Corp. (PHIO)." Disclosed 2026-09-29. https://desqlong.com/cards/0001683168-26-007481-1 (retrieved 2026-09-30).